A detailed history of Ifp Advisors, Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Ifp Advisors, Inc holds 437 shares of UTHR stock, worth $157,136. This represents 0.01% of its overall portfolio holdings.

Number of Shares
437
Previous 404 8.17%
Holding current value
$157,136
Previous $92,000 51.09%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$228.26 - $319.04 $7,532 - $10,528
33 Added 8.17%
437 $139,000
Q1 2024

Jul 30, 2024

SELL
$210.76 - $249.51 $27,820 - $32,935
-132 Reduced 24.63%
404 $92,000
Q4 2023

Jan 09, 2024

BUY
$214.88 - $256.94 $26,000 - $31,089
121 Added 29.16%
536 $117,000
Q3 2023

Oct 12, 2023

SELL
$211.82 - $248.24 $25,206 - $29,540
-119 Reduced 22.28%
415 $93,000
Q2 2023

Aug 04, 2023

BUY
$205.19 - $232.99 $63,608 - $72,226
310 Added 138.39%
534 $117,000
Q1 2023

Apr 18, 2023

SELL
$212.99 - $276.17 $71,990 - $93,345
-338 Reduced 60.14%
224 $50,000
Q4 2022

Feb 07, 2023

SELL
$205.95 - $280.43 $35,629 - $48,514
-173 Reduced 23.54%
562 $96,000
Q3 2022

Nov 08, 2022

BUY
$203.3 - $244.17 $52,858 - $63,484
260 Added 54.74%
735 $108,000
Q2 2022

Sep 06, 2022

BUY
$174.81 - $241.14 $83,034 - $114,541
475 New
475 $76,000
Q2 2022

Aug 12, 2022

SELL
$174.81 - $241.14 $83,034 - $114,541
-475 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$166.16 - $213.96 $72,113 - $92,858
434 Added 1058.54%
475 $85,000
Q1 2022

Aug 08, 2022

BUY
$166.16 - $213.96 $498 - $641
3 Added 7.89%
41 $7,000
Q3 2020

Oct 29, 2020

BUY
$99.9 - $121.13 $1,098 - $1,332
11 Added 40.74%
38 $4,000
Q2 2020

Aug 05, 2020

BUY
$92.74 - $125.82 $1,669 - $2,264
18 Added 200.0%
27 $3,000
Q3 2019

Nov 07, 2019

BUY
$74.85 - $85.99 $673 - $773
9 New
9 $1,000
Q1 2019

May 15, 2019

SELL
$107.15 - $126.84 $12,858 - $15,220
-120 Closed
0 $0
Q4 2018

Jan 23, 2019

SELL
$101.4 - $128.73 $7,807 - $9,912
-77 Reduced 39.09%
120 $13,000
Q2 2018

Aug 07, 2018

SELL
$101.14 - $118.31 $7,888 - $9,228
-78 Reduced 28.36%
197 $0
Q1 2018

Jun 03, 2019

BUY
$107.21 - $151.94 $2,573 - $3,646
24 Added 9.56%
275 $41,000
Q1 2018

May 09, 2018

SELL
$107.21 - $151.94 $2,573 - $3,646
-24 Reduced 8.73%
251 $0
Q3 2017

Oct 30, 2017

SELL
$114.6 - $136.81 $12,835 - $15,322
-112 Reduced 28.94%
275 $32,000
Q2 2017

Jun 03, 2019

BUY
N/A
152 Added 64.68%
387 $50,000
Q4 2016

Jun 03, 2019

SELL
N/A
-160 Reduced 40.51%
235 $34,000
Q2 2016

Jun 03, 2019

BUY
N/A
395
395 $42,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.